Journal of Materials Chemistry C
Paper
7.29 (dd, J1 ¼ 9 Hz, J2 ¼ 2 Hz, 1H), 7.01–6.98 (m, 2H), 4.18 (t, J ¼ 140–142 ꢃC. 1H NMR (500 MHz, CDCl3): d 8.42 (s, 1H), 7.65 (d, J
5 Hz, 2H), 3.88 (t, J ¼ 5 Hz, 2H), 3.75 (m, 2H), 3.69 (m, 2H), 3.66 ¼ 9 Hz, 1H), 7.33 (dd, J1 ¼ 9 Hz, J2 ¼ 2 Hz, 1H), 2.52 (s, 3H), 1.72
(m, 2H), 3.55 (m, 2H), 3.37 (s, 3H). 13C NMR (126 MHz, CDCl3) d (s, 6H). 13C NMR (126 MHz, CDCl3) d 123.7, 121.4, 117.6, 107.0,
159.4, 147.8, 145.4, 127.6, 125.9, 124.5, 124.5, 120.5, 117.9, 66.1, 31.7, 14.3; HRMS (EI): m/z (M+) calcd for C14H13F3N2O:
115.1, 108.4, 72.1, 71.0, 70.8, 70.7, 69.9, 67.6, 59.2; HRMS (ESI): 282.0980; found: 282.0981.
m/z ([M + H]+) calcd for C21H23F3N2O4: 425.1688; found:
425.1685.
2-Methyl-4-(2-phenyl-6-(triuoromethyl)imidazo[1,2-a]pyri-
din-3-yl)but-3-yn-2-ol (5b). Compound 4b (1.36 g, 4 mmol),
3-Bromo-2-methyl-6-(triuoromethyl)imidazo[1,2-a]pyridine puried by DCVC on SiO2 (1% MeOH in CH2Cl2) afforded 5b
1
(4a). NBS (0.53 g, 3 mmol) was added to 3a (0.6 g, 3 mmol) in dry (1.26 g, 91%), as colorless crystals, mp. 120–121 ꢃC. H NMR
acetonitrile (1 mL). The mixture was stirred for 1 h at r.t., and (500 MHz, CDCl3): d 8.43 (s, 1H), 8.23–8.21 (m, 2H), 7.73 (d, J ¼ 9
the resulting solid was ltered, dried, and used without further Hz, 1H), 7.43–7.35 (m, 4H). 13C NMR (126 MHz, CDCl3) d 149.9,
purication to afford 4a (0.69 g, 83%), as an off-white amor- 144.7, 132.6, 129.3, 128.6, 127.3, 123.9, 123.9, 122.2, 118.1,
phous solid, mp. 86 ꢃC. 1H NMR (500 MHz, CDCl3): d 8.39 (dd, J1 107.5, 70.6, 66.1, 31.5; HRMS (EI): m/z (M+) calcd for
¼ 1 Hz, J2 ¼ 2 Hz, 1H), 7.63 (d, J1 ¼ 9.5 Hz, J2 ¼ 1 Hz, 1H), 7.35
C
19H15F3N2O: 344.1136; found: 344.1138.
4-(2-(4-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)phenyl)-6-(tri-
(dd, J1 ¼ 9.5 Hz, J2 ¼ 1.5 Hz, 1H), 7.28 (d, J ¼ 7.0 Hz, 1H), 2.49 (s,
3H). 13C NMR (126 MHz, CDCl3) d 145.1, 144.4, 122.8, 122.8, uoromethyl)imidazo[1,2-a]pyridin-3-yl)-2-methylbut-3-yn-2-ol
120.4, 117.8, 95.0, 13.8; HRMS (EI): m/z (M+) calcd for (5c). Compound 4c (0.76 g, 1.5 mmol), puried by DCVC on SiO2
C9H6BrF3N2: 277.9666; found: 277.9665.
(75% Et2O in hexanes) afforded 5c (0.75 g, 99%), as colorless
3-Bromo-2-phenyl-6-(triuoromethyl)imidazo[1,2-a]pyridine crystals, mp. 78–79 ꢃC. 1H NMR (500 MHz, CDCl3): d 8.46 (d, J ¼
(4b). 3-Bromo-2-phenyl-6-(triuoromethyl)imidazo[1,2-a]pyri- 1 Hz, 1H), 8.19–8.17 (m, 2H), 7.69 (d, J ¼ 9 Hz, 1H), 7.36 (dd, J1 ¼
dine (4b) was prepared following the procedure for 4a. 9.5 Hz, J2 ¼ 1.5 Hz, 1H), 6.99–6.96 (m, 2H), 4.18 (t, J ¼ 5 Hz, 2H),
Compound 3b (1.57 g, 6 mmol) afforded 4b (1.69 g, 82%) as an 3.88 (t, J ¼ 5 Hz, 2H), 3.75 (m, 2H), 3.69 (m, 2H), 3.66 (m, 2H),
off-white amorphous solid, mp. 154 ꢃC. 1H NMR (500 MHz, 3.55 (m, 2H), 3.38 (s, 3H), 1.74 (s, 6H). 13C NMR (126 MHz,
CDCl3): d 8.55 (s, 1H), 8.14–8.13 (m, 2H), 7.75 (d, J ¼ 9.5 Hz, 1H), CDCl3) d 159.7, 149.6, 144.7, 128.7, 125.5, 123.8, 123.7, 122.0,
7.52–7.49 (m, 2H), 7.45–7.41 (m, 2H). 13C NMR (126 MHz, 117.8, 114.7, 107.4, 72.1, 71.0, 70.8, 70.7, 69.8, 67.6, 66.1, 59.2,
CDCl3) d 145.4, 144.8, 132.2, 129.0, 128.8, 128.1, 123.3, 123.2, 31.5; HRMS (ESI): m/z ([M + H]+) calcd for C26H30F3N2O5:
121.2, 118.5, 117.9, 117.6, 93.5; HRMS (EI): m/z (M+) calcd for 507.2107; found: 507.2108.
C
14H8F3N2: 339.9823; found: 339.9830.
3-Bromo-2-(4-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)phenyl)-
6-(triuoromethyl)imidazo[1,2-a]pyridine (4c). 3-Bromo-2-(4-(2-
(2-(2-methoxyethoxy)ethoxy)ethoxy)phenyl)-6-(triuoromethyl)-
General procedure for the synthesis of 3-ethynylimidazo[1,2-a]-
pyridine
imidazo[1,2-a]pyridine (4c) was prepared following the proce- A solution of alkynol (1 mmol) and NaOH (30 mg) in tolueneanh
ꢃ
dure for 4a. Compound 3c (1.06 g, 2.5 mmol) afforded 4c (1.09 g, (2 mL) was heated at 120 C under argon in an ACE pressure
86%) as an off-white amorphous solid, mp. 125–126 ꢃC. 1H NMR tube for 2 h. Then the mixture was evaporated with silica and
(500 MHz, CDCl3): d 8.52 (s, 1H), 8.01 (d, J ¼ 9 Hz, 2H), 7.71 (d, J puried as follows:
¼ 9.5 Hz, 1H), 7.40 (d, J ¼ 9 Hz, 1H), 7.04 (d, J ¼ 8.5 Hz, 2H), 4.20
3-Ethynyl-2-methyl-6-(triuoromethyl)imidazo[1,2-a]pyridine
(s, 2H), 3.95 (s, 2H), 3.76 (m, 2H), 3.70 (m, 2H), 3.66 (m, 2H), (6a). Compound 5a (283 mg, 1 mmol) and KOH (60 mg, 1.1
3.55 (s, 2H), 3.38 (s, 3H). 13C NMR (126 MHz, CDCl3) d 159.5, mmol) instead of NaOH, puried by DCVC on neutral
145.3, 144.6, 129.6, 124.9, 123.1, 121.0, 118.2, 117.4, 114.9, 92.7, aluminium oxide (1% MeOH in CH2Cl2) afforded 6a (145 mg,
72.1, 71.0, 70.8, 70.7, 69.8, 67.6, 59.2; HRMS (ESI): m/z ([M + H]+) 65%), as colorless crystals, mp. 109.5 ꢃC. H NMR (500 MHz,
1
calcd for C21H24BrF3N2O4: 504.0793; found: 504.0794.
CDCl3): d 8.54 (s, 1H), 7.64 (d, J ¼ 9 Hz, 1H), 7.38 (dd, J1 ¼ 9 Hz, J2
¼ 1.5 Hz, 1H), 3.97 (s, 1H), 2.52 (s, 3H). 13C NMR (126 MHz,
CDCl3) d 151.4, 144.6, 124.0, 124.0, 121.7, 117.7, 90.3, 70.9, 14.5;
HRMS (EI): m/z (M+) calcd for C11H7F3N2: 224.0561; found:
224.0566.
General procedure for the synthesis of 4-(imidazo[1,2-a]-
pyridin-3-yl)-2-methylbut-3-yn-2-ols (alkynols)
Pd(PPh3)2Cl2 (28 mg, 4 mol%) was added to the mixture of
3-Ethynyl-2-phenyl-6-(triuoromethyl)imidazo[1,2-a]pyridine
bromo-imidazopyridine (1 mmol) and 2-methylbut-3-yn-2-ol (6b). Compound 5b (345 mg, 1 mmol), puried by DCVC on SiO2
(0.2 mL, 2 mmol) in DMFanh (3 mL) and TEAanh (10 mL) under a (CH2Cl2) (228 mg, 79%) afforded 6b, as colorless crystals, mp.
continuous ow of argon. Aer bubbling through with argon for 160 ꢃC. 1H NMR (500 MHz, CDCl3): d 8.65 (m, 1H), 8.32–8.30 (m,
10–30 minutes, CuI (10 mg, 5 mol%) was added and the mixture 2H), 7.75 (d, J ¼ 9.5 Hz, 1H), 7.51–7.42 (m, 4H). 13C NMR (126
was heated at 80 ꢃC for 17 hours. Upon completion, the MHz, CDCl3) d 150.5, 144.9, 132.5, 129.4, 128.8, 127.5, 124.3,
resulting mixture was evaporated under reduced pressure with 124.2, 122.5, 118.3, 91.2, 72.3; HRMS (EI): m/z (M+) calcd for
celite/silica and puried as follows.
C16H9F3N2: 286.0718; found: 286.0726.
2-Methyl-4-(2-methyl-6-(triuoromethyl)imidazo[1,2-a]pyri-
3-Ethynyl-2-(4-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)phenyl)-
din-3-yl)but-3-yn-2-ol (5a). Compound 4a (0.56 g, 2 mmol), 6-(triuoromethyl)imidazo[1,2-a]pyridine (6c). Compound 5c
puried by DCVC on neutral aluminium oxide (1% MeOH in (634 mg, 1.25 mmol), puried by DCVC on SiO2 (1% MeOH in
CH2Cl2) afforded 5a (0.42 g, 74%), as colorless crystals, mp. CHCl3) afforded 6c (399 mg, 71%), as colorless crystals, mp.
4562 | J. Mater. Chem. C, 2014, 2, 4552–4565
This journal is © The Royal Society of Chemistry 2014